Home > Company > Introduction

Introduction

HELLO.
WE ARE MEDEXEL.


Started on July 1,2000 and started to produce related products such as insulin syringes, fennel, and a set of fluids for insulin injection.

Built with automated facilities to design and manufacture to meet customer needs, successful global experience and excellence.

We are a medical device manufacturer that continuously grows with technology and performs corporate ethics and social responsibility.

MedExel is a medical device manufacturing company which has manufactured insulin pen needles since 1, July 2000. MedExel designs the product for customers’ needs and always cares for the social responsibility based on the global experience and technology of the automatic system.

Founded in 2000 as a joint venture among German, US and Korean companies, MedExel has been innovated to meet customers’ needs, which are more comfortable and less painful devices for hypodermic injection of insulin for Diabetic cares.

Accumulated experience in developing various kinds of diabetic items for hypodermic injection has lead us to develop high-quality pen needles, which are compatible with most of the existing insulin pens. We have been able to successfully supply high quality and less painful pen needles, approved by CE, FDA 510K, NMPA and world wide customers.

MedExel is studying to develop more useful, safe product and trying to control quality for the customer’s satisfaction. The ultimate objective of MedExel is growing as a global leader by contributing to health of worldwide humanity.

Creativity and innovation is our future by accepting change with mind of challenge and enthusiasm. We would like to provide sincere service to our customers and do our best to continue developing more comfortable and less painful pen needles by keeping our ears open to customers’ opinions.

Thank you.

TEL : 82-31-299-1077 / E-mail : sales@medexel.co.kr / 252, GEUMGWANGOSAN-RO, GEUMKWANG-MYEON ANSEONG-SI, GYEONGGI-DO, REPUBLIC OF KOREA

Copyright(c) 2015 by MedExel Co., Ltd. All rights reserved.